CompoAtlas

CHITOSANE

Natural health product licensed in Canada

Other names
CHITOSAN, CHITOSAN WITH GARLIC EXTRACT, CHITOSANE AVEC EXTRAIT D'AIL
Licence holder
Laboratoire NewPharma GNTIK Inc. / NewPharma GNTIK Laboratory Inc.
NPN or DIN-HM
80088379
Status
Inactive licence
Licence date
17 September 2018
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Poly-bêta-(1,4)-2-amino-2-désoxy-d-glucose

Source : Chitine

500 mgNot calculated

Non-medicinal ingredients

Hydroxypropylcellulose, Dioxyde de silicium, Stéarate de magnésium, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 yearsminimum: 1 Capsule ; maximum: 2 Capsule3 Tous les jours

Uses authorised in Canada

Aide à diminuer le niveau de cholestérol sanguin total (et LDL). Aide à maintenir des niveaux de cholestérol sains. Utilisé en phytothérapie pour aider à diminuer les taux élevés de lipides sanguins/hyperlipidémie chez les adultes. Utilisé en phytothérapie pour aider au maintien de la santé cardiovasculaire chez les adultes.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80088379

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line